Replies to post #168332 on Biotech Values

[DewDiligence]

GILD’s guidance for the GT1 NDA submission is 2Q14 (same as ABBV’s).

[jq1234]

I believe GILD GT1 treatment experienced trial included cirrhotic patients, it also has 24-week arm.

Edit: GT1 treatment naïve trial included cirrhotic patients as well, it also has 24-week arm. Both trials are ongoing but not recruiting patients.